“Young Medical’s offering provides a logical extension to Vanguard’s capabilities."
David Cole, CEO of Vanguard
Vanguard has over two decades of experience in providing additional clinical capacity to replace or supplement existing healthcare infrastructure. The company can provide a variety of sophisticated mobile solutions ranging from operating rooms to sterilisation facilities. Its solutions can be deployed to maintain healthcare services during refurbishment, service reconfiguration, emergency situations such as natural disasters, or to alleviate long waiting lists.
Young Medical, based in Amersfoort in the Netherlands, provide modular medical facility solutions, both temporary and permanent to create a modern and safe environment for patients.
David Cole, CEO of Vanguard Healthcare Solutions said:
“Young Medical’s offering provides a logical extension to Vanguard’s capabilities. As our customers’ requirements increase in scale and complexity, we are increasingly providing mixed modality solutions. This acquisition means that we can now offer a truly holistic approach to the healthcare facilities market providing the flexibility to quickly deliver turnkey, customised solutions that can easily be adapted to meet changing demands in functionality or capacity”
He went on to say:
“Our modular approach to healthcare facilities will allow Vanguard to offer more customisation and complex solutions moving forward. With a minimum of disruption, modular buildings can easily be converted, updated or repurposed as needs change. This is particularly important in view of current imperative within the construction industry to reduce carbon emissions globally”
Simon Hollingsworth, Investment Director at Livingbridge, commented:
“We see this acquisition both as an important step in the extension of Vanguard’s portfolio and broadening our market reach, and giving us an additional foothold and entry point into European healthcare markets which can be scaled up to further extend our global reach. Vanguard are currently well established in markets outside of Europe”.